Chapter 37: Inflammatory and Structural Heart Disorders Flashcards
Valve orifice is smaller. Forward blood flow is impeded. Pressure differences reflect the degree. Constriction/narrowing.
Stenosis
Incompetent/insufficient. Incomplete closure of valve leaflets. Results in backward blood flow. Floppy.
Regurgitation
Majority of adult cases result from rheumatic heart disease. Scarring of valve leaflets and chordae tendineae. Less common causes: congenital mitral stenosis, Rheumatoid arthritis, SLE.
Mitral valve stenosis
Results in decreased blood flow from left atrium to left ventricle. Increase in left atrial pressure and volume causes increase pressure in pulmonary vasculature. Risk for atrial fibrillation d/t overloaded left atrium.
Mitral valve stenosis
Exertional dyspnea. Loud S1. Diastolic murmur (rumbling at apex. Low-pitched). Fatigue. Palpitations. Hoarseness (atrial englagement pressing on the laryngeal nerve), hemoptysis (d/t pulmonary HTN). Chest pain (from decreased CO and coronary perfusion), seizures/stroke (from emboli- stagnant blood in atria more likely to clot).
Mitral valve stenosis
Most cases caused by MI, chronic rheumatic heart disease, mitral valve prolapse, ischemic papillary muscle dysfunction, and IE. A defect in mitral leaflets, mitral annulus, chord tendineae, or papillary muscles.
Mitral valve regurgitation.
Allows blood to flow backward from the LV to the LA because of incomplete valve closure during systole. LV and LA must work harder to preserve an adequate CO.
Mitral valve regurgitation
Sudden increase in pressure and volume transmits to the pulmonary bed. This results in pulmonary edema and if untreated cariogenic shock
Acute mitral valve regurgitation
Left atrial enlargement d/t additional volume, ventricular dilation and hypertrophy–> decrease in CO.
Chronic mitral valve regurgitation
Thready peripheral pulses and cool, clammy extremities.
Acute mitral valve regurgitation
May remain asymptomatic for many years. Initial sx of LVF may include weakness, fatigue, palpitations, and dyspnea that gradually progress to orthopnea, PNS and peripheral edema. Increased LV volume leads to an audible S3.
Chronic mitral valve regurgitation.
Abnormality of mitral valve leaflets and the papillary muscle or chordae tendineae. Leaflets prolapse back into left atrium during systole. Usually benign with valve closing effectively. Potential complications. Unknown cause but genetic link in some.
Mitral valve prolapse.
Most pts are asymptomatic and remain so for their entire lives. Only 10% present with sx. Murmur d/t regurgitation that is louder in systole. Confirmed with echocardiography. Dysrhythmias can cause palpitations, light-headedness, and dizziness. IE may occur in some. May of may not have chest pain- cause is not known (may be a result of abnormal tension on the papillary muscles), unresponsive to nitrates. Treat sx with beta blockers (control palpitations, chest pain). Valvular surgery.
Mitral valve prolapse
Patient education: Antibiotic prophylaxis if MR present. Take drugs as prescribed. Healthy diet; avoid caffeine and OTC stimulants. Exercise. Contact HCP or emergency medical services if sx develop or worse (ie. palpitations, fatigue, SOB, anxiety)
Mitral valve prolapse
Congenital stenosis usually discovered in childhood, adolescence, or young adulthood. Can also be degenerative or caused by rheumatic fever.
Aortic valve stenosis
Causes obstruction of flow from the left ventricle to the aorta during systole. The effect is LV hypertrophy and increase myocardial O2 consumption d/t increased myocardial mass. As the disease progresses and compensatory mechanisms fail, reduced CO leads to decreased tissue perfusion, pulmonary HTN, and HF.
Aortic valve stenosis
S/S: develop when the valve orifice becomes about 1/2 of its normal size. Classic triad of angina, syncope, and exertion dyspnea, reflecting LVF. Ausculatory findings: normal or soft S1, diminished or absent S2, systolic murmur, and a prominent S4.
Use nitroglycerin cautiously- reduces preload and BP; can worsen chest pain.
Aortic valve stenosis
May be the result of primary disease of the aortic valve leaflets, the aortic root, or both. Trauma, IE, or aortic dissection can cause acute, which constitutes a life-threatening emergency. Chronic is generally the result of rheumatic heart disease, a congenital bicuspid aortic valve, syphilis, or chronic rheumatic conditions such as ankylosing spondylitis or reactive arthritis
Aortic valve regurgitation.
Causes retrograde (backward) blood flow from the ascending aorta into the LV during diastole, resulting in volume overload. The LV initially compensates for chronic by dilation and hypertrophy. Myocardial contractility eventually declines, and BV in the LA and pulmonary bed increases. This leads to pulmonary HTN and RVF.
Aortic valve regurgitation
S/S: sudden manifestations of cardiovascular collapse. Severe dyspnea, chest pain, and hypotension indicating LVF and cardiogenic shock (a life-threatening emergency)
Acute aortic valve regurgitation
May be asymptomatic for years. Exertion dyspnea, orthopnea, and PND can develop only after considerable heart dysfunction has occurred. Can develop a water-hammer pulse (a strong, quick beat that collapses immediately). Heart sounds may include a soft or absent S1, S3, or S4; and a soft, high-pitched diastolic murmur.
Chronic aortic valve regurgitation
Uncommon. Occurs more frequently than regurgitation. Occurs in pts with RF and IVDA. Right atrial enlargement and increased systemic venous pressure. Manifestations: peripheral edema, ascites, hepatomegaly, murmur with increased intensity on inspiration.
Tricuspid valve stenosis.
Almost always congenital. Causes right ventricular HTN and hypertrophy. S/S: fatigue, loud murmur.
Pulmonic valve stenosis
Diagnostic studies for valvular heart disease
History and physical examination. CT scan of chest with contrast is the gold standard for evaluating aortic disorders. Echocardiogram reveals valve structure, function, and heart chamber size. Chest x-ray reveals the heart size, altered pulmonary circulation, and valve calcification. An ECG identifies heart rate, rhythm, and any ischemia or ventricular hypertrophy. Cardiac catheterization detects pressure changes in the cardiac chambers, records pressure differences across the valves, and measures the size of the valve openings.
Nonsurgical tx of valvular heart disease/conservative therapies
Prophylactic ABX to prevent recurrent RF and IE. Dependent of valve involved and severity. Prevent exacerbations of HF, pulmonary edema, thromboembolisms, and recurrent endocarditis. Anticoagulant therapy prevents and treats systemic or pulmonary emboli. Used prophylactically in pts with a-fib.
An alternative tx for some pts with valvular heart disease. Split open fused commissures. Use for mitral, tricuspid and pulmonic stenosis. Done in cardiac cath lab. Involves threading a balloon-tipped catheter from the femoral artery or vein the the stenotic valve. The balloon is inflated in an attempt to separate the valve leaflets.
Percutaneous transluminal balloon valvuloplasty
Drugs to treat/control HF
Vasodilators (eg. nitrates, ACE inhibitors). Positive inotropes (eg. digoxin- increase contractility). Diuretics (decrease fluid). Beta adrenergic blockers. Antidysrhythmia drugs
Type can be valve repair or valve replacement. The procedure that is used depends on the valves involved, the pathology and severity of the disease, and the pt’s clinical condition. All types are palliative, not narrative, and pts require lifelong health care.
Surgical therapy
Usually the surgery of choice. Lower operative mortality rate than valve replacement and is often used in mitral or tricuspid valvular heart disease. valvulotomy, valvuloplasty, annuloplasty
Valve repair
May be required for mitral, aortic, tricuspid, and occasionally pulmonic valve disease. Used esp. for combined aortic stenosis/regurgitation. Can have mechanical or biologic valves.
Valve replacement
Made from bovine, porcine, and human cadaver tissue with some mad-made materials. Less durable, cause early calcification, tissue breakdown and leaflet stiffening. Do NOT require anticoagulation therapy. Not aortic valves b/c pressure is too high.
Biologic (tissue) valves
More durable, last longer. Increased risk of thromboembolism- requires long-term anticoagulation therapy. Cx: bleeding, valve leakage, endocarditis. May hear “click”.
Mechanical valves
Subjective data for valvular disease
Past medical hx. IVDA; fatigue; palpitations, weakness, activity intolerance, dizziness, fainting. DOE, cough, hemoptysis, orthopnea, PNS. Angolan or atypical chest pain.
Objective data for valvular disease
Fever, diaphoresis, flushing, cyanosis, clubbing, peripheral edema. Crackles, wheezes, hoarseness. S3 and S4. Dysrhythmias. Increase or decrease in pulse pressure; hypotension. Thready peripheral pulses. Hepatomegaly, ascites. Weight gain.
Nursing implementation
Individualize rest and exercise. Avoid strenuous activity. Discourage tobacco use. Ongoing cardiac assessments to monitor drugs effectiveness. Monitor INR.
The nurse is caring for a pt with aortic stenosis. For what should the nurse assess the pt?
a) systolic murmur
b) Pericardial friction rub
c) Diminished or absent S4
d) Low-pitched diastolic murmur
a) systolic murmur